Dulaglutides safety profile is consistent with other GLP-1 receptor agonists, with transient nausea being the most frequently reported adverse event (14.6% incidence). Dose escalation from 0.75 to 1.5 mg is recommended after at least four weeks, based on individual glycemic control needs [57]
In contrast, liraglutide, with its daily administration, had a lower adherence profile [47, 51]
poison control centers see steep rise in exposure calls tied to popular weight-loss drugs Poison control experts say calls related to GLP-1 weight-loss drugs like Wegovy and Zepbound are rising, with symptoms like nausea, vomiting and abdominal pain
For full details on common and serious side effects see the Victoza medication guide or talk to your healthcare provider or pharmacist
She punctuated her frustrations with a series of frowning emojis atop audio of an Im so hungry, chant
Lose Mode, which provides members with a consistent foundation for steady, sustainable progress